New eye injection aims to halt blindness from dry AMD in major trial
Disease control
Recruiting now
This study tests an experimental drug called ONL1204, given as an eye injection, to see if it can slow the growth of blind spots in people with geographic atrophy, an advanced form of dry age-related macular degeneration. About 324 adults aged 55 and older will receive either the…
Phase: PHASE2 • Sponsor: ONL Therapeutics • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC